JB- The company has publicly announced patents are in place through till 2032. Others have been filed- not yet granted. You seem to have a bee in your bonnet with OP- he has challenged you on various points and I for one was looking forward to very robust replies.
“Composition of matter” and “method of treatment” US
patents have been granted for RYONCIL and other
mesenchymal precursor / stromal cell products to treat
GVHD through to 2032.
Multiple “composition of matter”, “method of
treatment” and “manufacturing” patent applications
have recently been filed and are still undergoing
examination
Reg
Bell Potter Conference Up dates?, page-145
-
- There are more pages in this discussion • 101 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.35 |
Change
0.020(1.50%) |
Mkt cap ! $1.541B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.40 | $1.34 | $3.562M | 2.615M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | $1.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.36 | 17969 | 2 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |